Page last updated: 2024-10-24

candesartan and Bladder Neck Obstruction

candesartan has been researched along with Bladder Neck Obstruction in 2 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"To determine whether long-term administration of an angiotensin II type 1 receptor antagonist improves morphology and function in obstructed bladders."1.38Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder. ( Aikawa, K; Akaihata, H; Ishibashi, K; Kataoka, M; Kumagai, S; Sagawa, K; Sakai, T; Shiomi, H; Yamaguchi, O, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aikawa, K1
Sakai, T1
Ishibashi, K1
Shiomi, H1
Sagawa, K1
Kumagai, S1
Kataoka, M1
Akaihata, H1
Yamaguchi, O1
Miyazato, M1

Other Studies

2 other studies available for candesartan and Bladder Neck Obstruction

ArticleYear
Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
    International journal of urology : official journal of the Japanese Urological Association, 2012, Volume: 19, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Male; Placebos

2012
Editorial Comment to Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
    International journal of urology : official journal of the Japanese Urological Association, 2012, Volume: 19, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Male; Receptor

2012